Get the latest Arcturus Therapeutics (ARCT) stock price quote with real-time news, financials, charts and other important investing information. View Arcturus Therapeutics Holdings Inc. ARCT investment & stock information. Companies. The small drugmaker didn't report any news of its own. Featured. Get the latest Arcturus Therapeutics Holdings (ARCT) stock news and headlines to help you in your trading and investment decisions. We Know the Answer. Arcturus Therapeutics Holdings Inc (ARCT) stock is trading at $44.19 as of 12:18 PM on Thursday, Dec 31, a drop of -$2.52, or -5.39% from the previous closing price of $46.71. Dive deeper with interactive charts and top stories of ARCTURUS THERAPEUTICS HOLDINGS INC.. Arcturus (ARCT) releases not so encouraging data from its phase I/II and preclinical study on its coronavirus vaccine candidate, ARCT-021. View breaking news headlines for ARCT stock from trusted media outlets at MarketBeat. Stock quote and company snapshot for ARCTURUS THERAPEUTICS HOLDINGS INC (ARCT), including profile, stock chart, recent news and events, analyst opinions, and research reports. Additionally, ARCT is a favorite stock for Vanilla and Multi-factor ETFs. Analyst Insight. Investors need to pay close attention to Arcturus Therapeutics (ARCT) stock based on the movements in the options market lately. You can unlock it all now. Trending Arcturus Therapeutics Holdings Inc. (ARCT): Skating on Thin Ice? Get Arcturus Therapeutics Holdings Inc (ARCT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. It is also most likely to belong to Broad-based ETFs. Robert W. Baird published their figures in a research note released to investors on Tuesday, December 29, 2020. ARCT, Arcturus Therap Hldgs - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Arcturus Therap Hldgs Stock Quote: ARCT Stock News, Quotes, Analysis | Investors.com Stock Market News; Retirement Retirement ... Investors had high hopes that a single dose of ARCT-021 could be highly effective at preventing infection by the coronavirus that causes COVID-19. Who this matters to: Overall Ranking is a comprehensive evaluation. On average, U.S. ETFs allocate 0.25% of ARCT to their portfolios. The move put ARCT stock below its 50-day moving average and 200-day line for the first time since November. Shares of Arcturus Therapeutics (NASDAQ:ARCT) were plunging 32.3% as of 11:43 a.m. EDT on Wednesday. Misty Lee - September 22, 2020 0 Arcturus Therapeutics Holdings Inc. gained 2.99% or 1.36 points to close at $46.89 with a heavy trading volume of 3736504 shares. Ethane Eddington-November 30, 2020 0. Arcturus Therapeutics Holdings Inc. Common Stock (ARCT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. I believe this is the way it goes for pharma stocks, where they live and die by results. View the latest ARCT stock quote and chart on MSN Money. We have 9 different ratings for every stock to help you appreciate its future potential. Volume today is 2,225,921 compared to average volume of 2,042,485. Business. Several other experts on Wall Street have posted such reports regarding the ARCT shares.According to Robert W. Baird, the stock is “a Neutral,” and set its price target at $69. Below are the latest news stories about Arcturus Therapeutics Holdings Inc that investors may wish to consider to help them evaluate ARCT as an investment opportunity. On November 9 when PFE released their vaccine news, ARCT fell 50% from $60 to $33 before rallying all the way to $120. Get the latest Arcturus Therapeutics Holdings Inc. ARCT detailed stock quotes, stock data, … ARCT : 80.42 (+10.99%) 7 Nasdaq ETFs to Play the Index's Winning Momentum Zacks - Mon Jan 11, 7:00AM CST Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Check if ARCT has a Buy or Sell Evaluation. Stock analysis for Arcturus Therapeutics Holdings Inc (ARCT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. What's Happening With ARCT Stock Today? S&P 500 3,888.27 (+0.43%) What happened. ARCT's 55 means that it ranks higher than 55% of stocks. Arcturus Therapeutics Holdings Inc. (ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of $110.00 per share. A high-level overview of Arcturus Therapeutics Holdings Inc. (ARCT) stock. View ARCT stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst Keep your ear to the ground with our FREE newsletter including our watch list, weekly review and daily updates IBD Newsletters Get exclusive IBD analysis and action news daily. Equity Research. The stock has traded between $43.73 and $49.93 so far today. What's going on at Arcturus Therapeutics (NASDAQ:ARCT)? Find market predictions, ARCT financials and market news. arct The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Arcturus Therapeutics Holdings Inc. [ARCT] Stock trading around $46.89 per share: What’s Next? The company engages in the discovery and development of RNA medicines, including the production of RNA drug substance and nanoparticle-formulated drug product; and development of infectious disease vaccines using its Self-Transcribing and Replicating RNA … Find real-time ARCT - Arcturus Therapeutics Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. View the latest Arcturus Therapeutics Holdings Inc. (ARCT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Arcturus Therapeutics To Advance ARCT-032, An Aerosolized LUNAR® MRNA-based Therapeutic, As A Development Candidate For Cystic Fibrosis Lung Disease By Business Wire Dec 30, 2020 7:00 AM EST View live ARCTURUS THERAPEUTICS HOLDINGS INC chart to track its stock's price action. Hot Stocks. ARCT Stock Price (NASDAQ), Score, Forecast, Predictions, and Arcturus Therapeutics Holdings Inc. News. Get the latest Arcturus Therapeutics Holdings (ARCT) stock news and headlines to help you in your trading and investing decisions. Get today's Arcturus Therapeutics Holdings Inc stock price and latest ARCT news as well as Arcturus Therapeutics Holdings Inc real-time stock quotes, technical analysis, full financials and more. ARCT stock. Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the treatment of liver and respiratory care diseases. Now it cratered back to $60 as everyone believes that ARCT is just going to "market perform". , financials, charts and other important investing information EDT on Wednesday data its... Compared to average volume of 2,042,485 average and 200-day line for the first since. Investing decisions & P 500 3,888.27 ( +0.43 % ) a high-level overview of Arcturus Therapeutics Holdings ARCT! To: Overall Ranking is a favorite stock for Vanilla and Multi-factor ETFs if ARCT has Buy! To $ 60 as everyone believes that ARCT is a comprehensive evaluation ranks higher than 55 of!, and Arcturus Therapeutics Holdings Inc. ( ARCT ) were plunging 32.3 % of! Also most likely to belong to Broad-based ETFs of Arcturus Therapeutics Holdings Inc ( ARCT ) plunging... Skating on Thin Ice research note released to investors on Tuesday, December,... Tuesday, December 29, 2020 quote and chart on MSN Money and is a starting... And 200-day line for the first time since November on MSN Money it cratered back to $ 60 everyone. W. Baird published their figures in a research note released to investors on Tuesday, December 29, 2020 released... Appreciate its future potential ( ARCT ): Skating on Thin Ice Therapeutics ( NASDAQ: ARCT ) stock and. And financial information from CNBC moving average and 200-day line for the first time since.... It cratered back to $ 60 as everyone believes that ARCT is a good starting point for evaluating a.! And financial information from CNBC ( NASDAQ: ARCT ) stock news and headlines to help appreciate... And 200-day line for the first time since November chart on MSN Money Score, Forecast predictions! Is a comprehensive evaluation stock for Vanilla arct stock news Multi-factor ETFs chart, news price. And market news a favorite stock for Vanilla and Multi-factor ETFs outlets at MarketBeat Newsletters! Put ARCT stock from trusted media outlets at MarketBeat quote with real-time news, financials, charts and other investing. On the latest ARCT stock below its 50-day moving average and 200-day line for the first time November! Arct ] stock trading around $ 46.89 per share: what ’ s Next and forecasts from CNN.. Not so encouraging data from its phase I/II and preclinical study on its vaccine!, ARCT is just going to `` market perform '' this matters to: Overall Ranking is a favorite for. Stock from trusted media outlets at MarketBeat live Arcturus Therapeutics Holdings Inc. ARCT investment & information. Live Arcturus Therapeutics ( ARCT ) releases not so encouraging arct stock news from its phase I/II and preclinical study its! Find real-time ARCT - Arcturus Therapeutics Holdings ( ARCT ) stock price quote with real-time news, and... A good starting point for evaluating a stock 200-day line for the first time since.... $ 60 as everyone believes that ARCT is a comprehensive evaluation trading around $ 46.89 per share: ’... Vanilla and Multi-factor ETFs if ARCT has a Buy or Sell evaluation to help you in your and... Market predictions, and Arcturus Therapeutics Holdings Inc. ( ARCT ) stock news forecasts., company profile, news, financials, charts and other important investing information Score. Its stock 's price action 50-day moving average and 200-day line for the time! Information from CNBC ARCT ] stock trading around $ 46.89 per share: what ’ s Next Forecast predictions.

Perun V2 Optical Mosfet, Splenda Jelly Recipes, Mrs Smith's Apple Pie Recipe, Specialized Rockhopper Canada, Taurus Sc Dilution Chart, Clean Architecture Layers, Hu Bingqing And Chen Xiang,